Literature DB >> 29578526

An In Vivo Assessment of Blood-Brain Barrier Disruption in a Rat Model of Ischemic Stroke.

Hamdollah Panahpour1, Mehdi Farhoudi2, Yadollah Omidi3, Javad Mahmoudi2.   

Abstract

Ischemic stroke leads to vasogenic cerebral edema and subsequent primary brain injury, which is mediated through destruction of the blood-brain barrier (BBB). Rats with induced ischemic stroke were established and used as in vivo models to investigate the functional integrity of the BBB. Spectrophotometric detection of Evans blue (EB) in the brain samples with ischemic injury could provide reliable justification for the research and development of novel therapeutic modalities. This method generates reproducible results, and is applicable in any laboratory without a need for special equipment. Here, we present a visualized and technical guideline on the detection of the extravasation of EB following induction of ischemic stroke in rats.

Entities:  

Mesh:

Year:  2018        PMID: 29578526      PMCID: PMC5931698          DOI: 10.3791/57156

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  33 in total

1.  Quantitative evaluation of BBB permeability after embolic stroke in rat using MRI.

Authors:  Quan Jiang; James R Ewing; Guang Liang Ding; Li Zhang; Zheng Gang Zhang; Lian Li; Polly Whitton; Mei Lu; Jiani Hu; Qing Jiang Li; Robert A Knight; Michael Chopp
Journal:  J Cereb Blood Flow Metab       Date:  2005-05       Impact factor: 6.200

2.  Impacts of blood-brain barrier in drug delivery and targeting of brain tumors.

Authors:  Yadollah Omidi; Jaleh Barar
Journal:  Bioimpacts       Date:  2012-02-02

3.  Global cerebral ischemia due to cardiocirculatory arrest in mice causes neuronal degeneration and early induction of transcription factor genes in the hippocampus.

Authors:  B W Böttiger; P Teschendorf; J J Krumnikl; P Vogel; R Galmbacher; B Schmitz; J Motsch; E Martin; P Gass
Journal:  Brain Res Mol Brain Res       Date:  1999-03-05

4.  Mild induced hypertension improves blood flow and oxygen metabolism in transient focal cerebral ischemia.

Authors:  Hwa Kyoung Shin; Masaki Nishimura; Phillip B Jones; Hakan Ay; David A Boas; Michael A Moskowitz; Cenk Ayata
Journal:  Stroke       Date:  2008-03-13       Impact factor: 7.914

5.  Effects of hyperthermia on infarct volume in focal embolic model of cerebral ischemia in rats.

Authors:  Raza Noor; Chen Xu Wang; Ashfaq Shuaib
Journal:  Neurosci Lett       Date:  2003-10-02       Impact factor: 3.046

6.  The potential use of H102 peptide-loaded dual-functional nanoparticles in the treatment of Alzheimer's disease.

Authors:  Chi Zhang; Xiaoyao Zheng; Xu Wan; Xiayan Shao; Qingfeng Liu; Zheming Zhang; Qizhi Zhang
Journal:  J Control Release       Date:  2014-08-04       Impact factor: 9.776

Review 7.  Suppression of inflammation in ischemic and hemorrhagic stroke: therapeutic options.

Authors:  Timothy J Kleinig; Robert Vink
Journal:  Curr Opin Neurol       Date:  2009-06       Impact factor: 5.710

8.  Candesartan attenuates ischemic brain edema and protects the blood-brain barrier integrity from ischemia/reperfusion injury in rats.

Authors:  Hamdollah Panahpour; Ali Akbar Nekooeian; Gholam Abbas Dehghani
Journal:  Iran Biomed J       Date:  2014

9.  Alpha-Tocopherol Reduces Brain Edema and Protects Blood-Brain Barrier Integrity following Focal Cerebral Ischemia in Rats.

Authors:  Adel Haghnejad Azar; Shahrbanoo Oryan; Shahab Bohlooli; Hamdollah Panahpour
Journal:  Med Princ Pract       Date:  2016-09-07       Impact factor: 1.927

Review 10.  Blood-brain barrier transport machineries and targeted therapy of brain diseases.

Authors:  Jaleh Barar; Mohammad A Rafi; Mohammad M Pourseif; Yadollah Omidi
Journal:  Bioimpacts       Date:  2016-12-05
View more
  1 in total

1.  Effects of β1-adrenergic receptor blockade on the cerebral microcirculation in the normal state and during global brain ischemia/reperfusion injury in rabbits.

Authors:  Nobumasa Asano; Sohei Hishiyama; Tadahiko Ishiyama; Masakazu Kotoda; Takashi Matsukawa
Journal:  BMC Pharmacol Toxicol       Date:  2020-02-21       Impact factor: 2.483

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.